Randomised open-label trial of insulin lispro protamin suspension versus insulin glargine once daily in basal-bolus therapies with insulin lispro in type 2 diabetes patients

被引：0
|
作者：
Giugliano, D.
Cleall, S.
Pontiroli, A. E.
Koivisto, V.
机构：
来源：
DIABETOLOGIA | 2011年 / 54卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1037
引用
收藏
页码：S421 / S422
页数：2
相关论文
共 50 条
  • [31] Evaluation of thrice-daily injections of insulin Lispro Mix 50/50 versus basal-bolus therapy in perioperative patients with type 2 diabetes
    Cho K.Y.
    Nakagaki O.
    Miyoshi H.
    Akikawa K.
    Astumi T.
    Diabetology International, 2014, 5 (2) : 117 - 121
  • [32] INSULIN LISPRO WITH CONTINUOUS SUBCUTANEOUS INSULIN INFUSION IS SAFE AND EFFECTIVE IN PATIENTS WITH TYPE 2 DIABETES: A RANDOMIZED CROSSOVER TRIAL OF INSULIN LISPRO VERSUS INSULIN ASPART
    Thrasher, James
    Bhargava, Anuj
    Rees, Tina M.
    Wang, Tao
    Guzman, Cristina B.
    Glass, Leonard C.
    ENDOCRINE PRACTICE, 2015, 21 (03) : 247 - 257
  • [33] Once-daily basal insulin glargine versus thrice-daily prandial insulin lispro in people with type 2 diabetes on oral hypoglycaemic agents (APOLLO): an open randomised controlled trial (vol 371, pg 1073, 2008)
    Bretzel, R. G.
    Nuber, U.
    Landgraf, W.
    Owens, D. R.
    Bradley, C.
    Linn, T.
    LANCET, 2008, 372 (9640): : 718 - 718
  • [34] Switching to once-weekly insulin icodec versus once-daily insulin glargine U100 in individuals with basal-bolus insulin- treated type 2 diabetes (ONWARDS 4): a phase 3a, randomised, open-label, multicentre, treat-to-target, trial
    Mathieu, Chantal
    Asbjornsdottir, Bjorg
    Bajaj, Harpreet S.
    Lane, Wendy
    Matos, Ana Laura S. A.
    Murthy, Sreenivasa
    Stachlewska, Karolina
    Rosenstock, Julio
    LANCET, 2023, 401 (10392): : 1929 - 1940
  • [35] Effects of Insulin Lispro Mix 25 and Insulin Lispro Mix 50 on Postprandial Glucose Excursion in Patients with Type 2 Diabetes: A Prospective, Open-Label, Randomized Clinical Trial
    Wei Li
    Fan Ping
    Lingling Xu
    Meicen Zhou
    Hongmei Li
    Yaxiu Dong
    Yuxiu Li
    Diabetes Therapy, 2018, 9 : 699 - 711
  • [36] Effects of Insulin Lispro Mix 25 and Insulin Lispro Mix 50 on Postprandial Glucose Excursion in Patients with Type 2 Diabetes: A Prospective, Open-Label, Randomized Clinical Trial
    Li, Wei
    Ping, Fan
    Xu, Lingling
    Zhou, Meicen
    Li, Hongmei
    Dong, Yaxiu
    Li, Yuxiu
    DIABETES THERAPY, 2018, 9 (02) : 699 - 711
  • [37] Comparison of a Multiple Daily Insulin Injection Regimen (Basal Once-Daily Glargine Plus Mealtime Lispro) and Continuous Subcutaneous Insulin Infusion (Lispro) in Type 1 Diabetes A randomized open parallel multicenter study
    Bolli, Geremia B.
    Kerr, David
    Thomas, Reena
    Torlone, Elisabetta
    Sola-Gazagnes, Agnes
    Vitacolonna, Ester
    Selam, Jean Louis
    Home, Philip D.
    DIABETES CARE, 2009, 32 (07) : 1170 - 1176
  • [38] Cost-utility analysis of once-weekly insulin icodec and once-daily insulin glargine in patients with type 2 diabetes receiving basal-bolus insulin therapy in China
    Dai, Nan
    Su, Xiaorong
    Wang, Yong
    DIABETES OBESITY & METABOLISM, 2025, 27 (01): : 377 - 386
  • [39] Basal Supplementation of Insulin Lispro Protamine Suspension Versus Insulin Glargine and Detemir for Type 2 Diabetes Meta-analysis of randomized controlled trials
    Esposito, Katherine
    Chiodini, Paolo
    Capuano, Annalisa
    Petrizzo, Michela
    Improta, Maria Rosaria
    Giugliano, Dario
    DIABETES CARE, 2012, 35 (12) : 2698 - 2705
  • [40] Efficacy and safety of insulin lispro protamine suspension versus insulin glargine added to oral antihyperglycaemic medications and exenatide in patients with type 2 diabetes
    Arakaki, R. F.
    Blevins, T. C.
    Liljenquist, D. R.
    Wise, J. K.
    Jiang, H. H.
    Schneider, K. K.
    Jacobson, J. G.
    Martin, S. A.
    Jackson, J. A.
    DIABETOLOGIA, 2010, 53
12345